Search Results - "Latif, Tahir"
-
1
Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia
Published in Nature medicine (01-04-2017)“…The intrinsic resistance of BCR-ABL-expressing chronic myeloid leukemia stem cells to treatment with tyrosine-kinase inhibitors requires growth-factor…”
Get full text
Journal Article -
2
Influence of Rituximab on Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Role of Prophylaxis—A Systematic Review of Prospective Studies
Published in Clinical lymphoma, myeloma and leukemia (01-08-2015)“…Abstract Despite the improvement in overall survival in patients with diffuse large B-cell lymphoma (DLBCL) in the rituximab era, the occurrence of central…”
Get full text
Journal Article -
3
Prophylactic CNS directed therapy in systemic diffuse large B cell lymphoma
Published in Critical reviews in oncology/hematology (01-09-2014)“…Abstract Overall survival in diffuse large B-cell lymphoma (DLBCL) has significantly improved in the last decade, especially after the incorporation of…”
Get full text
Journal Article -
4
Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles
Published in Translational oncology (01-06-2015)“…Abstract Pancreatic cancer remains one of the most intractable cancers, with a dismal prognosis reflected by a 5-year survival of ~ 6%. Since early disease…”
Get full text
Journal Article -
5
Thalidomide and its analogues in the treatment of Multiple Myeloma
Published in Experimental hematology & oncology (11-09-2012)“…Multiple myeloma is an incurable malignant disorder of mature B-cells that predominantly affects the elderly. The immunomodulatory drug (IMiD) thalidomide and…”
Get full text
Journal Article -
6
Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC)
Published in Investigational new drugs (01-01-2005)“…JM-216 is an orally bioavailable platinum compound with activity against many tumor models. The objective of this study was to determine the safety profile and…”
Get full text
Journal Article -
7
The biology of myelodysplastic syndromes: unity despite heterogeneity
Published in Hematology reports (23-06-2010)“…Myelodysplastic syndromes (MDS) traditionally have been grouped together as a disease entity based on clinical phenomena seen in association. Despite the…”
Get full text
Journal Article -
8
Outcomes and prognostic assessment of post-transplant lymphoproliferative disorder
Published in Journal of clinical oncology (01-06-2022)“…e19548 Background: Post-transplant lymphoproliferative disorder (PTLD) is the most common malignancy after solid organ transplantation (SOT) in adults, apart…”
Get full text
Journal Article -
9
Effect of plant spacing on incidence of rice planthoppers in transplanted rice crop
Published in International journal of tropical insect science (01-03-2021)“…The rice planthoppers (RPHs) are considered as important rice pests in Asia including Pakistan. As phloem-feeders, they can cause severe losses to rice…”
Get full text
Journal Article -
10
Rational Polypharmacological Targeting of FLT3, JAK2, ABL and ERK1 By Pluripotin Suppresses the Adaptive Resistance to FLT3 Inhibitors in AML
Published in Blood (15-11-2022)Get full text
Journal Article -
11
Advanced pancreatic cancer outcomes and the impact of COVID-19 pandemic: The experience of an academic cancer center
Published in Journal of clinical oncology (20-01-2024)“…626 Background: The COVID-19 pandemic increased all-cause mortality and disrupted healthcare delivery in the United States. Interruptions in cancer screening…”
Get full text
Journal Article -
12
Momelotinib Is a Highly Potent Inhibitor of FLT3-Mutant AML
Published in Blood (23-11-2021)“…Approximately one-third of AML patients harbor kinase activating mutations in FLT3. Several small-molecule first generation FLT3 tyrosine kinase inhibitors…”
Get full text
Journal Article -
13
Poster: HL-172 FDG-PET/CT as a Tool for Early Detection of Bleomycin-Induced Pulmonary Toxicity
Published in Clinical lymphoma, myeloma and leukemia (01-10-2022)Get full text
Journal Article -
14
HL-172 FDG-PET/CT as a Tool for Early Detection of Bleomycin-Induced Pulmonary Toxicity
Published in Clinical lymphoma, myeloma and leukemia (01-10-2022)Get full text
Journal Article -
15
Pattern of Marginal Local Failure in a Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Resectable and Borderline Resectable Pancreas Cancer
Published in American journal of clinical oncology (01-03-2019)“…The main objectives of this study were to prospectively evaluate the safety and efficacy of stereotactic body radiation therapy (SBRT) in the neoadjuvant…”
Get full text
Journal Article -
16
Loss of DUSP1 Is Synthetic Lethal to JAK2V617F
Published in Blood (29-11-2018)“…Introduction. Myeloproliferative neoplasm (MPNs) are clonal stem cell disorders characterized by increased production of mature blood cells. Ph-negative MPNs…”
Get full text
Journal Article -
17
Survival outcomes of post-transplant lymphoproliferative disorder: A 12-year analysis
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e19543 Background: Post-transplant lymphoproliferative disorder (PTLD) is a rare and potentially fatal complication of chronic immunosuppression…”
Get full text
Journal Article -
18
Pancreatic cancer and diabetes: The effects of race and genes
Published in Journal of clinical oncology (20-01-2024)“…627 Background: Pancreatic cancer and diabetes mellitus (DM) have been shown to be connected, but the genetic associations between the two have not been well…”
Get full text
Journal Article -
19
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial
Published in Nature medicine (01-04-2023)“…Autologous hematopoietic stem cell transplantation (ASCT) improves survival in multiple myeloma (MM). However, many individuals are unable to collect optimal…”
Get full text
Journal Article -
20
Immune checkpoint inhibitors in liver transplant: a case series
Published in Journal of gastrointestinal oncology (29-04-2023)“…Immune checkpoint inhibitors (ICIs) in the setting of liver transplant (LT) pose a risk of rejection and hold unclear benefit in both the neoadjuvant…”
Get full text
Journal Article